Numerous studies have confirmed that tumor-infiltrating immune cells (TIICs), especially cytotoxic T lymphocyte (CD8+ T) cells, significantly affect the prognosis of cancer patients and the effect of immunotherapy and chemotherapy [10–12]. Here, CD8A is linked to neoplasm.